Scientists Identify Gene Pathway Controlling Gut Immunity

A study reveals how the COMPASS pathway and Wdr82 gene maintain essential immune tolerance in the intestine.

Updated on Oct. 29, 2026 in Life Sciences

Microscopic view of intestinal cellular structures with delicate luminous filaments illustrating a biological regulatory pathway. — Researchers at St. Jude Children’s Research Hospital have identified the Wdr82 gene as a critical regulator of immune tolerance in the human intestine. AI Illustration. Upload story photo >

Live Poll

Do you believe new discoveries in immune regulation will lead to effective treatments for autoimmune diseases?

Researchers have discovered a gene-regulatory pathway that allows regulatory T cells to suppress immune responses to gut bacteria. This mechanism is critical for maintaining immune tolerance and preventing lethal intestinal inflammation.

Why it matters

The finding explains how the body distinguishes between beneficial gut microbiota and harmful pathogens, potentially offering a target for treating intestinal inflammatory conditions.

The study utilized a CRISPR screen to isolate Wdr82 as a primary factor in regulatory T cell function. Experiments confirmed that antibiotic-induced depletion of gut bacteria prevents inflammation in mice lacking this gene.

The players

St. Jude Children's Research Hospital

This facility is a world-renowned pediatric treatment and research institution focused on catastrophic diseases in children.

The details

Scientists at St. Jude Children's Research Hospital found that the COMPASS pathway, specifically the Wdr82 gene, is vital for regulatory T cells. While Wdr82 loss disrupts these suppressive cells, inflammatory effector T cells remain largely unaffected, leading to an imbalance that triggers severe bowel issues.

October 28, 2026: The research findings were published in the journal Science Advances.

The Big Picture

This discovery marks a significant paradigm shift in our understanding of the development of regulatory T-cell therapies for autoimmune diseases. By mapping the Wdr82 pathway, researchers have identified a foundational mechanism that explains how immune cells maintain essential tolerance to the microbiome.

Understanding this gene-regulatory pathway could eventually lead to new medical treatments for chronic intestinal inflammation and autoimmune disorders. Future research will focus on whether human genetic variations in these pathways drive similar immune responses in clinical settings.

The takeaway

Maintaining a balanced immune response in the gut is essential for preventing severe chronic inflammation. Researchers suggest that targeting specific gene-regulatory pathways could provide more precise interventions for patients with intestinal disorders.